Bringing the fundamentals into focus…
Back to CareDx, Inc.
How CareDx, Inc. stacks up
CDNA · against 246 other Healthcare companies of similar size
Valuation
43/ 100
Below the middle of the pack.
Ranked #153 of 247 · scores higher than 37% of peers
Bars: peers in each 10-point band of the valuation score28 peers with a valuation score of 40–49, including CDNA · Click a bar to see the companies
Why valuation scores 43?
Weighted metrics compared with all Healthcare companies.A mix: stronger free cash flow yield, but weaker EBITDA yield than most Healthcare peers.
- less operating profit (EBITDA) for the company's total value: weaker than 67% of peers. EBITDA yield: 0.3% vs peer median 4.0%
- Earnings yield is close to the peer norm. Earnings yield: 2.4% vs peer median 1.5%
- more free cash flow for the price paid: stronger than 61% of peers. Free cash flow yield: 1.8% vs peer median 0.0%
Metric by metric
Position: dot = CDNA, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | CDNA | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 243 reported | 2.4% | 2.5% | 48% | 30% | |
| EBITDA yieldHigher is better · 244 reported | 0.3% | 4.6% | 27% | 50% | |
| Free cash flow yieldHigher is better · 133 reported | 1.8% | 0.7% | 62% | 20% | |
| Book yieldHigher is better · 245 reported | 9.3% | 26.5% | 18% | Context only |
Ranking by valuation score
Top 5 and the companies ranked around CDNA| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 21.3B HKD (≈$2.7B) | 99 | 68 | |
| 1 | 52.2B HKD (≈$6.7B) | 99 | 56 | |
| 1 | 37.3B HKD (≈$4.8B) | 99 | 90 | |
| 4 | 21.1B HKD (≈$2.7B) | 98 | 67 | |
| 4 | 428.3B JPY (≈$2.9B) | 98 | 59 | |
| 149 | 5.7B USD | 44 | 38 | |
| 149 | 5.9B USD | 44 | 39 | |
| 153 | 17.8B CNY (≈$2.5B) | 43 | 39 | |
| 153 | 40.3B SEK (≈$4.0B) | 43 | 79 | |
| 153 | 4.6B USD | 43 | 65 | |
| 156 | 5.1B USD | 42 | 52 | |
| 156 | 2.7B USD | 42 | 56 | |
| 156 | 5.8B USD | 42 | 38 | |
| 156 | 303.5B INR (≈$3.6B) | 42 | 47 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score